Home / Recalls / RLC Labs Inc. / D-1618-2020

D-1618-2020 Class I Terminated

Recalled by RLC Labs Inc. — Phoenix, AZ

Recall Details

Product Type: Drugs
Report Date: September 23, 2020
Initiation Date: August 25, 2020
Termination Date: November 8, 2023
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: N/A

Product Description

Nature Throid, 2 Grain (130 mg) Thyroid USP [Liothyronine (T3) 18 mcg, Levothyroxine (T4) 76 mcg], packaged in a) 30-count bottles (NDC 64727-3308-4) and b)100-count bottles (NDC 64727-3308-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024

Reason for Recall

Subpotent Drug: FDA analysis found product to be subpotent

Distribution Pattern

Nationwide in the United States

Code Information

Lot #: 109264, Exp. Date 10/2022

Other recalls by RLC Labs Inc.

D-1596-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38 mc (August 25, 2020)
D-1612-2020 Class II — WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1 (August 25, 2020)
D-1609-2020 Class II — WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Ta (August 25, 2020)
D-1614-2020 Class I — WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4 (August 25, 2020)
D-1607-2020 Class II — WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP packaged in a) 1,000 (August 25, 2020)
D-1601-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4) 6 (August 25, 2020)
D-1602-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 m (August 25, 2020)
D-1605-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 114 (August 25, 2020)
D-1617-2020 Class I — Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg, L (August 25, 2020)
D-1598-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 4.5 mcg and levothyroxine (T4) 19 (August 25, 2020)